Risk factors associated with secondary hyperparathyroidism in patients with chronic kidney disease
Authors:
- 8 June 2016
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 12 (2) , 1206-1212
Abstract
Secondary hyperparathyroidism (SHPT) is common in patients with chronic kidney disease (CKD), and its development and progression are affected by various factors. The aim of the present study was to identify the risk factors for SHPT in patients with CKD. A retrospective study was performed in 498 patients (305 males and 193 females) with CKD, observed in the The First Hospital of Jilin University between January 2008 and December 2012. The demographic, clinical and laboratory data were collected. Patients were divided into the SHPT group (n=424) with elevated serum parathyroid hormone (PTH) expression levels and the control group (n=74) with normal serum PTH expression levels. Univariate and multivariate regression analyses were employed to explore the risk factors for SHPT. Serum PTH expression levels in women with CKD were significantly higher than in men (P=0.047). Serum PTH expression levels were positively correlated with the expression levels of serum creatinine (P<0.01), phosphorus (P<0.01), C‑reactive protein (P<0.05), triglyceride (P<0.05), cholesterol (P<0.05) and low-density lipoprotein cholesterol (P<0.05), but were negatively correlated with the expression levels of hemoglobin (P<0.05), calcium (P<0.01) and CO2 combining power (P<0.01) in patients with CKD. Multivariate analysis showed that the serum expression levels of creatinine [µmol/l; odds radio (OR), 1.003; 95% confidence interval (CI), 1.002-1.004; P=0.001] and phosphorus (mmol/l; OR, 2.19; 95% CI, 1.254‑3.826; P=0.006) in patients with CKD significantly influenced serum PTH expression levels. The SHPT risk factors include female gender, low calcium, high phosphorus, acidosis, anemia, hypertension, hyperlipidemia and micro‑inflammation, with blood phosphorus and creatinine being independent risk factors.Keywords
This publication has 40 references indexed in Scilit:
- The Roles of the Skeleton and Phosphorus in the CKD Mineral Bone DisorderAdvances in Chronic Kidney Disease, 2011
- Renal lipid metabolism and lipotoxicityCurrent Opinion in Nephrology and Hypertension, 2010
- Risk factors for progression of chronic kidney diseaseCurrent Opinion in Pediatrics, 2010
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- Anemia as a risk factor for chronic kidney diseaseKidney International, 2007
- High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patientsNephrology Dialysis Transplantation, 2007
- Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal studyKidney International, 2006
- FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate HomeostasisJournal of Bone and Mineral Research, 2004
- Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEXJournal of Biological Chemistry, 2003
- Oxidative stress in hemodialysis patients: Is NADPH oxidase complex the culprit?Kidney International, 2002